CD164 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.282800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.416000E-01
Normal-vs-Stage2
4.140600E-01
Normal-vs-Stage3
6.901200E-01
Normal-vs-Stage4
7.443700E-02
Stage1-vs-Stage2
8.731000E-01
Stage1-vs-Stage3
9.549400E-01
Stage1-vs-Stage4
3.430000E-01
Stage2-vs-Stage3
8.295000E-01
Stage2-vs-Stage4
3.941800E-01
Stage3-vs-Stage4
5.599400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.550200E-01
Normal-vs-AfricanAmerican
1.863050E-01
Normal-vs-Asian
3.589800E-01
Caucasian-vs-AfricanAmerican
9.626200E-01
Caucasian-vs-Asian
2.405800E-01
AfricanAmerican-vs-Asian
4.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.161200E-01
Normal-vs-Female
4.478200E-01
Male-vs-Female
4.091600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.114400E-01
Normal-vs-Age(41-60Yrs)
3.508400E-01
Normal-vs-Age(61-80Yrs)
4.563000E-01
Normal-vs-Age(81-100Yrs)
2.122800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.147400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.885600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.014800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.041000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.001200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.316600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.668400E-01
Normal-vs-Daily Drinker
8.565800E-01
Normal-vs-Weekly Drinker
6.736800E-01
Normal-vs-Occasional Drinker
2.055800E-01
Normal-vs-Social Drinker
7.036400E-01
Non Drinker-vs-Daily Drinker
7.169800E-02
Non Drinker-vs-Weekly Drinker
2.642800E-01
Non Drinker-vs-Occasional Drinker
9.976600E-01
Non Drinker-vs-Social Drinker
3.092200E-01
Daily Drinker-vs-Weekly Drinker
6.373800E-01
Daily Drinker-vs-Occasional Drinker
4.480100E-02
Daily Drinker-vs-Social Drinker
6.080800E-01
Weekly Drinker-vs-Occasional Drinker
1.924240E-01
Weekly Drinker-vs-Social Drinker
9.461600E-01
Occasional Drinker-vs-Social Drinker
2.670400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.920200E-01
Normal-vs-Grade 2
1.283560E-01
Normal-vs-Grade 3
1.576830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.693000E-01
Grade 1-vs-Grade 3
8.511800E-01
Grade 1-vs-Grade 4
2.920200E-01
Grade 2-vs-Grade 3
9.660000E-01
Grade 2-vs-Grade 4
1.283560E-01
Grade 3-vs-Grade 4
1.576830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.191200E-01
Normal-vs-NonDiabetic
4.293400E-01
Diabetic-vs-NonDiabetic
4.886400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.048200E-01
Normal-vs-NoPancreatitis
4.686200E-01
Pancreatitis-vs-NoPancreatitis
9.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.910200E-01
Normal-vs-N1
4.364400E-01
N0-vs-N1
2.187800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.140600E-01
Normal-vs-TP53-NonMutant
6.114000E-01
TP53-Mutant-vs-TP53-NonMutant
8.208800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
